PD1(hi) CD200(hi) CD4(+) exhausted T cell increase immunotherapy resistance and tumour progression by promoting epithelial–mesenchymal transition in bladder cancer

BACKGROUND: Bladder cancer (BLCA) is one of the most diagnosed cancers in humans worldwide. Recently, immunotherapy has become a main treatment option for BC. However, most BLCA patients do not respond to immune checkpoint inhibitors or relapse after immunotherapy. Therefore, it is very important to...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Chun, Duan, Lianhui, Li, Hongmu, Liu, Xuefei, Cai, Taonong, Yang, Yang, Yin, Yuting, Chang, Wuguang, Zhong, Leqi, Zhang, Lin, Cheng, Yixin, Qin, Haide, Wen, Zhesheng, Wang, Huiyun, Mai, Shijuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265167/
https://www.ncbi.nlm.nih.gov/pubmed/37313656
http://dx.doi.org/10.1002/ctm2.1303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265167/
https://www.ncbi.nlm.nih.gov/pubmed/37313656
http://dx.doi.org/10.1002/ctm2.1303

Ejemplares similares